Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Critical Reviews in Oncology/Hematology|November 1, 2025
Balancing risks and benefits of immune checkpoint inhibitors in patients with pre-existing immune-mediated inflammatory diseases: A comprehensive reviewClara Salva de Torres, Ernesto Trallero-Araguas, David Marmolejo, et al.
Molecular Cancer Therapeutics|March 25, 2014
Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancerMercedes Marín-Aguilera, Jordi Codony-Servat, Òscar Reig, et al.
The Lancet. Oncology|October 22, 2011
Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective studyJesus Garcia-Donas, Emilio Esteban, Luis Javier Leandro-García, et al.
European Urology Open Science|May 31, 2022
Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 StudyMagnus Lindskog, Anna Laurell, Anders Kjellman, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 5, 2021
Measures to evaluate quality of care in renal cancer: results of a Delphi study in SpainVicente Guillem Porta, Carlos Camps, Miguel Ángel Climent Durán, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 21, 2024
A Signal-Finding Study of Abemaciclib in Heavily Pretreated Patients with Metastatic Castration-Resistant Prostate Cancer: Results from CYCLONE 1Neeraj Agarwal, Daniel Castellano, Teresa Alonso-Gordoa, et al.
Critical Reviews in Oncology/Hematology|April 22, 2017
Recent advances in genitourinary tumors: A review focused on biology and systemic treatmentAránzazu González Del Alba, José Ángel Arranz, Javier Puente, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 4, 2026
Patient selection for triplet therapy with darolutamide in metastatic castration-sensitive prostate cancer and patterns of administration: a Spanish multicenter studyTeresa Alonso-Gordoa, Ovidio Fernández-Calvo, Icíar García-Carbonero, et al.
Frontiers in Oncology|May 15, 2026
Distinct protein and metabolic profiles in patients with advanced clear-cell renal cell carcinoma treated with sunitinib: a study of the Spanish oncology genitourinary groupGuillermo Quintás, Elena Sanmartín, Alicia Garcia-Gimenez, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2018
Phase 2 Randomized Study of Radiation Therapy and 3-Year Androgen Deprivation With or Without Concurrent Weekly Docetaxel in High-Risk Localized Prostate Cancer PatientsJoan Carles, Enrique Gallardo, Montserrat Doménech, et al.
Pageof 7